Final Programme for the 28th conference of the European Network of Teratology Information Services and the Joint ENTIS-ETS Education Course, Budapest, Saturday 2nd to Tuesday 5th September, 2017 is now available!

The final programme of the 28th ENTIS conference, the Education Course on Hormones and Brain Development and the symposium on pre-term births is now available for download. The Education course and the Symposium are co-organised with the European Teratology Society. For the other details regarding the conference, education course, registration and accomodation please click here.  

» Read more

ACE inhibitors in pregnancy: Recent study from the U.S. suggests no increase in risk of major malformations with exposure during the first trimester among women with hypertension

In January 2017 Obstetrics & Gynecology published an article on Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations“ by Brian T Bateman et al. As data on the teratogenic potential of ACE inhibitor (ACEI) are partly conflicting, this pharmacoepidemiologic study wanted to analyze the association between first trimester ACEI exposure and the risk of overall major malformations, of cardiovascular […]

» Read more

Collaborative ENTIS study into the risk of adverse pregnancy outcomes following maternal varenicline use

A collaborative ENTIS study recently published in Reproductive Toxicology (Volume 67, Pages 26-34) has provided no signal that varenicline is a major human teratogen. This collaborative ENTIS study was undertaken by researchers based at teratology information services in the United Kingdom, Israel, France (Paris), Germany (Berlin), Australia, the Netherlands, Finland and Turkey (Izmir), who collectively joined data from over 400 […]

» Read more

Antipsychotics in Pregnancy: Large Cohort Study from the US Investigates Risk for Congenital Malformations

In August 2016 JAMA Psychiatry published the results of a large pharmacoepidemiological cohort study by Krista Huybrechts et al., examining the risk for congenital malformations overall as well as cardiac malformations associated with first-trimester exposure to antipsychotics. While previous studies documented the outcome of several hundred exposed pregnancies at most, this study cohort included a nationwide sample of more than […]

» Read more

Publication of recent study of pregnancy outcome after methylphenidate exposure

A collaborative study published in J Clin Psychiatry by ENTIS and MotherToBaby affiliated researchers did not suggest that first trimester in utero exposure be associated with increased risk of congenital malformations.   Methylphenidate is a central nervous system stimulant medicinally used in the treatment of attention deficit disorders. Data on its safety in human pregnancy are sparse. A recent prospective, comparative, […]

» Read more

News from the ENTIS-ISoP-NFIF Education Course and the 27th Annual ENTIS Conference 2016

The European Network of Teratology Information Services (ENTIS) in association with the International Society of Pharmacovigilance (ISOP) and the Norwegian PhD School of Pharmacy (NFIF) recently provided an education course entitled Risk Assessment of Drug Use During Pregnancy and Lactation, which was delivered in the headquarters of the Berlin-Brandenburg Academy of Sciences and Humanities in Berlin, Germany. The two day […]

» Read more

Final programme of the ENTIS-ISoP-NFIF Training Course “Risk assessment of drug use during pregnancy and lactation” and 27th ENTIS conference is now available…

Agenda of the ENTIS-ISoP-NFIF Training Course “Risk assessment of drug use during pregnancy and lactation” Berlin, June 2-3 , 2016 Scientific programme of 27th Conference of the European Network of Teratology Information Services (ENTIS) Berlin, June 4-5, 2016      

» Read more